Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nutrition and Cancer|May 26, 2020
How to Prevent Sarcopenia Occurrence during Neoadjuvant Chemotherapy for Oesogastric Adenocarcinoma?Marlène Voisinet, Aïna Venkatasamy, Hefzi Alratrout, et al.
BMC Cancer|October 20, 2010
Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatmentBenoît Romain, Agnès Neuville, Nicolas Meyer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2022
Sarcopenia remaining after intensive nutritional feeding support could be a criterion for the selection of patients for surgery for oesogastric junction adenocarcinomaPierre de Mathelin, Simone Manfredelli, Jean-Baptiste Delhorme, et al.
Molecular Cancer|March 18, 2014
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancerBenoît Romain, Muriel Hachet-Haas, Serge Rohr, et al.
Critical Reviews in Oncology/Hematology|March 21, 2016
Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancersJean-Baptiste Delhorme, Delphine Antoni, Kimberley S Mak, et al.
International Journal of Surgery (London, England)|November 27, 2015
Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?Jean-Baptiste Delhorme, Laure Dupont-Kazma, Pietro Addeo, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|August 5, 2020
Is Lanreotide Really Useful in High Output Stoma? Comparison between Lanreotide to Conventional Antidiarrheal Treatment AloneYannis Mesli, Lise Holterbach, Jean-Baptiste Delhorme, et al.
Oncology|June 2, 2017
Surgery Is an Effective Option after Failure of Chemoradiation in Cancers of the Anal Canal and Anal MarginJean-Baptiste Delhorme, François Severac, Waisse Waissi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 20, 2022
CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancerJean-Baptiste Delhorme, Emilie Bersuder, Chloé Terciolo, et al.
Pageof 4